Connect Biopharma Holdings Limited IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Connect Biopharma Holdings Limited | CNTB - NASDAQ |
$15.00-$17.00 | $17.00 | $19.55 | 11.25 million ADSs | 3/19/2021 |
| Jefferies, SVB Leerink, Piper Sandler, CICC | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-02-26 Terms Added 2021-03-12 | ||||||
Connect Biopharma Holdings Limited Quote & Chart - Click for current quote - CNTB
IPO Boutique aggregates information on public companies and private companies, such as "CNTB" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Connect Biopharma Holdings Limited (adapted from Connect Biopharma Holdings Limited prospectus):
They are a global clinical-stage biopharmaceutical company developing therapies for the treatment of T cell-driven inflammatory diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a global clinical-stage biopharmaceutical company developing therapies for the treatment of T cell-driven inflammatory diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "CNTB" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.